# SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

> clinical trial · VERIFIED · 2026-09-02

Status: ACTIVE_NOT_RECRUITING · Sponsor: Sanofi · Condition: Plasma Cell Myeloma Recurrent

- Company: Sanofi
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05405166

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.